Caricamento...
Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
Based on the role of oxidative stress in the pathogenesis of Graves’ hyperthyroidism (GH) and Graves’ Orbitopathy (GO), a therapy with the antioxidant agent selenium has been proposed and a number of studies have been performed, both in vitro and in vivo. In GH, reactive oxygen species (ROS) contrib...
Salvato in:
| Pubblicato in: | Front Endocrinol (Lausanne) |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7870989/ https://ncbi.nlm.nih.gov/pubmed/33574798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.608428 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|